Breast Atypical Hyperplasia

general

A general term that refers to atypical hyperplastic proliferations of the epithelial cells in the breast parenchyma. Examples include atypical ductal hyperplasia, atypical lobular hyperplasia, and columnar cell hyperplasia with atypia.

18

Centers

29

Active Trials

$4.5B

Cancer Funding

Specific Cancer Types(3)

NameCenters
Atypical Ductal Breast Hyperplasia11
Breast Atypical Lobular Hyperplasia8
Breast Atypical Ductal Hyperplasia7

Top Centers for Breast Atypical Hyperplasia(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
High-Volume Research Center
78.0
2
University of Michigan Rogel Cancer CenterAnn Arbor, MI
NCI Comprehensive
Active Research Program
60.0
3
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
60.0
4
University of Illinois Cancer CenterChicago, IL
Active Research Program
60.0
5
Cancer Center at IllinoisUrbana, IL
42.0
6
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
—
7
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
—
8
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
—
9
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
—
10
Duke Cancer InstituteDurham, NC
NCI Comprehensive
—
11
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
—
12
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
13
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
—
14
Cleveland Clinic Cancer CenterCleveland, OH
—
15
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
—
16
Boston University Cancer CenterBoston, MA
—
17
University of Cincinnati Cancer CenterCincinnati, OH
—
18
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →